Trials / Completed
CompletedNCT06303557
Effect of ESPB on Intraoperative Remifentanil Consumption
Effect of ESPB on Intraoperative Remifentanil Consumption in Lumbar Spine Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Atatürk Chest Diseases and Chest Surgery Training and Research Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
In recent years, regional anesthesia techniques have also been frequently applied to patients for pain relief. Erector spinae plane block (ESPB), is among the regional anesthesia techniques frequently used in lumbar spine surgery. General anesthesia (GA) is the main method of anesthesia for lumbar spine surgery. However, GA can only inhibit the projection system of the cortical limbic system or hypothalamic cortex. GA cannot completely block the transmission of peripheral noxious stimulus to the central nervous system and cannot effectively inhibit the intraoperative stress response. With the addition of peripheral blocks such as ESPB, lower remifentanil consumption, and more stable hemodynamics are expected by providing preemptive analgesia in patients. As a result of all these; it was aimed to compare the intraoperative remifentanil consumption of patients who underwent preoperative ESPB in patients who will undergo lumbar spine surgery resection under GA with those who underwent postoperative ESPB.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Preoperative Erector Spinae Plane Block | Erector spinae plane block will be performed bilaterally, under US guidance, before the surgical operation, after the induction of anesthesia, and when the patient is placed in the prone position. |
| DRUG | Postoperative Erector Spinae Plane Block | Erector spinae plane block will be performed unilaterally, under US guidance, after the surgical operation, under general anesthesia, and when the patient is placed in the prone position. |
Timeline
- Start date
- 2024-01-31
- Primary completion
- 2025-11-03
- Completion
- 2025-11-13
- First posted
- 2024-03-12
- Last updated
- 2025-11-26
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06303557. Inclusion in this directory is not an endorsement.